{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:18:54Z","timestamp":1767374334121,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Public health issues related to chronic pain management and the risks of opioid misuse and abuse remain a challenge for practitioners. Data on the prevalence of disorders related to the use of prescribed opioids in patients suffering from chronic pain remains rather patchy, in particular because of the absence of a gold standard for their clinical assessment. We estimated the prevalence of prescription opioid misuse (POM), using a specific and validated opioid misuse scale (POMI-5F scale), in adults with chronic non-cancer pain. Nine-hundred-fifty-one (951) patients with opioids prescription and followed-up in pain clinics and addictology centers for chronic non-cancer pain (CNCP) completed the survey interview. The results suggest that 44.4% of participants have POM, accompanied by overuse (42.5%), use of opioids for effects other than analgesia (30.9%), withdrawal syndrome (65.7%), and craving (6.9%). The motivations cited for POM, apart from pain relief, were to calm down, relax and improve mood. POM was shown to be related to male sex (OR 1.52), young age (OR 2.21) and the presence of nociplastic pain (OR 1.62) of severe intensity (OR 2.31), codeine use (OR 1.72) and co-prescription of benzodiazepines (OR 1.59). Finally, despite the presence of three subgroups of misusers, no factor was associated with the intensity of misuse, reinforcing the view that distinguishing between strong and weak opioids is not appropriate in the context of use disorder. Almost half of patients with CNCP misuse their prescribed opioid. Practitioners should be attentive of profiles of patients at risk of POM, such as young, male patients suffering from severe nociplastic pain, receiving prescription for codeine and a co-prescription for benzodiazepine. We encourage French-speaking practitioners to use the POMI-5F scale to assess the presence of POM in their patients receiving opioid-based therapy.<\/jats:p><jats:p><jats:bold><jats:ext-link>Clinical Trial Registration<\/jats:ext-link><\/jats:bold><jats:ext-link>clinicaltrials.gov<\/jats:ext-link>, identifier NCT03195374<\/jats:p>","DOI":"10.3389\/fphar.2022.947006","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T08:28:14Z","timestamp":1662625694000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Cross-sectional study of the prevalence of prescription opioids misuse in French patients with chronic non-cancer pain: An update with the French version of the POMI scale"],"prefix":"10.3389","volume":"13","author":[{"given":"Nicolas","family":"Kerckhove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Delage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9lian","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Cantagrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Delorme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chouki","family":"Chenaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Poma Network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: definition, pitfalls, and adjustment methods","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"key":"B2","unstructured":"Actualit\u00e9 - antalgiques opio\u00efdes: l\u2019ANSM publie un \u00e9tat des lieux de la consommation en France - ANSM2021"},{"key":"B3","doi-asserted-by":"publisher","first-page":"E119","DOI":"10.36076\/ppj.2014\/17\/e119","article-title":"Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011","volume":"17","author":"Atluri","year":"2014","journal-title":"Pain Physician"},{"key":"B4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.neubiorev.2020.12.015","article-title":"Analgesic opioid use disorders in patients with chronic non-cancer pain: a holistic approach for tailored management","volume":"121","author":"Bertin","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/10550887.2011.581961","article-title":"Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria","volume":"30","author":"Boscarino","year":"2011","journal-title":"J. Addict. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pain.2007.01.014","article-title":"Development and validation of the current opioid misuse measure","volume":"130","author":"Butler","year":"2007","journal-title":"Pain"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100592","DOI":"10.1016\/j.eclinm.2020.100592","article-title":"Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: findings from a 5-year prospective cohort study","volume":"28","author":"Campbell","year":"2020","journal-title":"EClinicalMedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/pds.4056","article-title":"Incidence of tramadol shopping behavior in a retrospective cohort of chronic non-cancer pain patients in France","volume":"25","author":"Chenaf","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","article-title":"Prescription opioid analgesic use in France: trends and impact on morbidity-mortality","volume":"23","author":"Chenaf","year":"2019","journal-title":"Eur. J. Pain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.drugalcdep.2016.03.014","article-title":"Understanding the demand side of the prescription opioid epidemic: does the initial source of opioids matter?","volume":"173","author":"Cicero","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B11","first-page":"205","volume-title":"Royal Society of Medicine International Congress and Symposium Series","author":"Coniam","year":"1989"},{"key":"B12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1042\u20131052","DOI":"10.1007\/s12630-022-02210-7","article-title":"Transcultural validation of a French-European version of the prescription opioid misuse Index scale (POMI-5F)","volume":"69","author":"Delage","year":"2022","journal-title":"Can J. Anaesth."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain-United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/02791072.2019.1621410","article-title":"High prevalence of misuse of prescribed opioid analgesics in patients with chronic non-cancer pain","volume":"51","author":"Eiden","year":"2019","journal-title":"J. Psychoact. Drugs"},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD012509","DOI":"10.1002\/14651858.CD012509.pub2","article-title":"Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of cochrane reviews","volume":"10","author":"Els","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/ijerph18042097","article-title":"Analgesic opioid misuse and opioid use disorder among patients with chronic non-cancer pain and prescribed opioids in a pain centre in France","volume":"18","author":"Guillou-Landreat","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inf."},{"key":"B19","unstructured":"Bon usage des m\u00e9dicaments opio\u00efdes : antalgie, pr\u00e9vention et prise en charge du trouble de l\u2019usage et des surdoses2022"},{"key":"B20","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ejp.1736","article-title":"European* clinical practice recommendations on opioids for chronic noncancer pain - Part 1: role of opioids in the management of chronic noncancer pain","volume":"25","author":"H\u00e4user","year":"2021","journal-title":"Eur. J. Pain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: a literature review","volume":"11","author":"H\u00f8jsted","year":"2007","journal-title":"Eur. J. Pain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12875-018-0775-9","article-title":"Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study","volume":"19","author":"Just","year":"2018","journal-title":"BMC Fam. Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e026871","DOI":"10.1136\/bmjopen-2018-026871","article-title":"Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study","volume":"9","author":"Just","year":"2019","journal-title":"BMJ Open"},{"key":"B24","first-page":"S111","article-title":"Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2)","volume":"20","author":"Kaye","year":"2017","journal-title":"Pain Physician"},{"key":"B25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jsat.2008.02.001","article-title":"Prescription opioid misuse Index: a brief questionnaire to assess misuse","volume":"35","author":"Knisely","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/pme.12465","article-title":"Characteristics of chronic noncancer pain patients assessed with the opioid risk tool in a Canadian tertiary care pain clinic","volume":"15","author":"Lakha","year":"2014","journal-title":"Pain Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1017\/S0033291711002145","article-title":"Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions","volume":"42","author":"Martins","year":"2012","journal-title":"Psychol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurol.2016.05.004","article-title":"Opioid use for the management of chronic non-cancer pain: French guidelines","volume":"172","author":"Moisset","year":"2016","journal-title":"Rev. Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.lpm.2016.02.014","article-title":"Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain","volume":"45","author":"Moisset","year":"2016","journal-title":"Presse Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/7854_2015_422","article-title":"Over-the-Counter codeine-from therapeutic use to dependence, and the grey areas in between","volume":"34","author":"Nielsen","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"CD006605","DOI":"10.1002\/14651858.CD006605.pub2","article-title":"Long-term opioid management for chronic noncancer pain","volume":"2018","author":"Noble","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.pain.2013.06.035","article-title":"Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations","volume":"154","author":"O\u2019Connor","year":"2013","journal-title":"Pain"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7818","DOI":"10.3390\/ijerph18157818","article-title":"Evaluation of medicine abuse trends in community pharmacies: the medicine abuse observatory (MAO) in a region of southern Europe","volume":"18","author":"Perell\u00f3","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0304-3959(86)90091-6","article-title":"Chronic use of opioid analgesics in non-malignant pain: report of 38 cases","volume":"25","author":"Portenoy","year":"1986","journal-title":"Pain"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e76499","DOI":"10.1371\/journal.pone.0076499","article-title":"Misuse and dependence on non-prescription codeine analgesics or sedative H1 antihistamines by adults: a cross-sectional investigation in France","volume":"8","author":"Roussin","year":"2013","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/j.pain.0000000000001009","article-title":"Defining chronic pain in epidemiological studies: a systematic review and meta-analysis","volume":"158","author":"Steingr\u00edmsd\u00f3ttir","year":"2017","journal-title":"Pain"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.pain.2013.05.053","article-title":"Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations","volume":"154","author":"Smith","year":"2013","journal-title":"Pain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jsat.2016.11.003","article-title":"Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement","volume":"73","author":"Stumbo","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"B39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugpo.2015.09.007","article-title":"Misuse of non-prescription codeine containing products: recommendations for detection and reduction of risk in community pharmacies","volume":"27","author":"Van Hout","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/ije\/28.3.409","article-title":"Comparison of self-report data and medical records data: results from a case-control study on prostate cancer","volume":"28","author":"Zhu","year":"1999","journal-title":"Int. J. Epidemiol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.947006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T08:28:35Z","timestamp":1662625715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.947006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":41,"alternative-id":["10.3389\/fphar.2022.947006"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.947006","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"article-number":"947006"}}